UAN vs BIOX
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Sep 25, 2026
UAN
BIOX
Investment Advisor Scores
BIOX
AI Analyst Insights
Detailed Metrics Comparison
| Metric | UAN | BIOX | Winner |
|---|---|---|---|
|
Valuation
Lower P/E and PEG ratios suggest a stock may be undervalued relative to earnings and growth. Value investors prefer lower multiples. |
|||
| Forward P/E | 10.2041 | 14.9925 | UAN |
| PEG Ratio | -1.3 | 1.9521 | Tie |
|
Growth
Higher revenue and earnings growth rates indicate a company is expanding faster. Strong growth often justifies premium valuations. |
|||
| Revenue Growth | 20.0% | -23.4% | UAN |
| Earnings Growth | 99.9% | 34.4% | UAN |
|
Quality & Profitability
Higher Tradestie Score and profit margins reveal how efficiently a company operates. Strong profitability indicates competitive advantages. |
|||
| Tradestie Score | 34.9/100 | 49.0/100 | BIOX |
| Profit Margin | 23.7% | -19.7% | UAN |
|
Risk Profile
Lower Beta and Implied Volatility values indicate reduced market risk. Conservative investors favor stocks with less price volatility. |
|||
| Beta | 1.00 | 1.00 | Tie |
|
Sentiment
AI Recommendation reflects overall analyst and proprietary sentiment. Stronger recommendations signal higher conviction. |
|||
| AI Recommendation | AVOID NEW MONEY | HOLD | BIOX |
Relative Price Performance (Last 90 Days)
Current Technical Phase
UAN
NeutralMixed signals - no dominant trend phase, RSI 44
BIOX
NeutralMixed signals - no dominant trend phase, RSI 37
Fundamentals Snapshot
| Metric | UAN | BIOX |
|---|---|---|
| Market Cap | — | — |
| Forward P/E | 10.2 | 6.8 |
| Trailing P/E | 8.2 | — |
| Revenue (TTM) | — | — |
| Revenue Growth | 0.2% | -0.2% |
| Gross Margin | 0.5% | 0.3% |
| Operating Margin | 0.4% | -0.2% |
| EPS | 15.26 | -0.74 |
| Dividend Yield | 0.12% | — |